The cell must maintain the integrity of its genome despite the continual induction of DNA damage. Sources of DNA damage include UV radiation and drugs such as cis-diamminedichloroplatinum(II) (cis-DDP or cisplatin), trans-DDP, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), 4-nitroquinoline oxide (4NQO), and nitrogen mustard (HN2). The cell survives exposure to these agents primarily through the repair of the damaged DNA by mechanisms that include photoreactivation and nucleotide excision repair (NER). Photoreactivation is a specific mechanism for the light-dependent repair of UV-induced cyclobutane pyrimidine dimers, while NER is a versatile process capable of repairing a wide range of DNA lesions by removing a nucleotide patch containing the lesion and resynthesizing the damaged strand (17) .
The yeast Saccharotnyces cerevisiae repairs DNA damage by both NER and photoreactivation. NER is catalyzed by multiple proteins, several of which are essential for the pathway, including those encoded by the RADJ, RAD2, RAD3, RAD4, RAD10 (13) , RAD14 (1) , and SSL2 (15) genes. Photoreactivation is catalyzed by the enzyme DNA photolyase, a 66-kDa protein encoded by the PHR1 gene (37) . Photolyase binds to the cyclobutane dimer, absorbs a photon from the visible spectrum, and utilizes the photon's energy to cleave the cyclobutane ring, restoring the DNA to its native conformation (33) . Photolyase also enhances the NER of cyclobutane dimers in both Escherichia coli and S. cerevisiae (31, 34) , possibly by facilitating recognition of the dimer by other NER enzymes. Interestingly, although photoreactivating activity is also present in E. coli, Drosophila melanogaster, fish, birds, and marsupial mammals, it is undetectable in humans (25, 30) .
In human cells, NER is defective in the autosomal recessive disease xeroderma pigmentosum (XP), which is characterized by severe sensitivity to UV radiation and by extreme susceptibility to skin cancer (14) . Cell fusion experiments have identified seven complementation groups, implying that multiple cultured in YPD medium (1% yeast extract, 2% peptone, 2% dextrose) or in synthetic complete (SC) medium as appropriate.
PHRI and RAD2 plasmid constructs. The single-copy centromeric plasmids YCplaclll and pRS314 carry the LEU2 and TRP1 selectable markers, respectively. The multicopy 2pim plasmid YEp13 carries the LEU2 marker. For simplicity, the plasmid vectors will be referred to as follows: YCplaclll will be called pc, pRS314 will be called pc', and YEp13 will be referred to as p2,u. The RAD2 gene (kindly provided by W. Seide in the plasmid pWS502) was isolated as a 4.5-kb SalT fragment and subcloned into pc'. The PHR1 gene was provided by D. Schild as a 6.4-kb insert in the plasmid p2pu. A 3.1-kb PvuII fragment containing the PHR1 gene (35) was subcloned into the plasmids pc and p2,.
A frameshift mutation was inserted into the PHR1 gene in both pc and p2,u by digestion with NcoI, which cleaves at a single site within the PHRJ gene. The resultant 4-base staggered ends were filled in with Klenow polymerase and blunt end ligated with T4 DNA ligase.
Yeast cells were transformed by a modification of the lithium acetate protocol, as described by Elble (12) . For all experiments, the double mutant strain XS was transformed with pc', with or without the RAD2 insert, and with either pc or p2,u, with or without a PHR1 insert. All transformants were subsequently grown in SC media lacking both leucine and tryptophan. The PHR1 knockout strains were transformed with either pc or p2,u, with or without the PHR1 insert, and were grown in SC media lacking leucine. The UV sensitivity and photoreactivation phenotypes of all transformants were confirmed as described previously (37) .
Preparation and storage of drugs. cis-DDP and trans-DDP were prepared as 1-mg/ml stocks in buffer containing 3 mM NaCl and 1 mM NaH2PO4 (pH 7.4; Pt buffer) and stored at -20°C in the dark. MNNG was prepared as a 15 mM stock in ethanol and stored at -20°C for binding assays or as a 20 mM stock in 0.1 M sodium acetate (pH 5.2) for survival assays. 4NQO was modified to its activated derivative, 4-hydroxyaminoquinoline-N-oxide (4HAQO), by the method of Panigrahi and Walker (27) Preparation of damaged DNA. The DNA probe used in the binding assays was a 148-bp DNA fragment derived from the bacterial chloramphenicol acetyltransferase gene, which was end labeled with 32P and exposed to UV radiation at a dose of 6,000 J/m2 as described previously (28) . This dose induces approximately 140 cyclobutane dimers per plasmid molecule (41) .
The competitor DNA was supercoiled pRSVneo plasmid DNA, which was damaged by UV radiation at a dose of 6,000 J/m2 at a DNA concentration of 250 ng/ml (28) . DNA was damaged by cis-DDP and trans-DDP with a molar ratio of 5 of drug to DNA phosphate in Pt buffer at 370C for 24 h (9). The introduction of DNA cross-links by either agent was monitored as a shift in electrophoretic mobility of the DNA (29) . Under these conditions, the number of lesions introduced per plasmid molecule was estimated to be approximately 350 for cis-DDP (9) and approximately 480 for trans-DDP (16) . DNA was damaged by MNNG at molar ratios of 5 and 25 in a buffer containing 10 mM Tris (pH 7.5) and 50 mM NaCl at 370C for 24 h (29) . The presence of MNNG-induced damage was confirmed by the inhibition of BamHI cleavage due to alkylation of guanine residues in its recognition site, GGATCC. The number of lesions induced by MNNG could not be determined, since MNNG induces both alkylation and apurinic sites, and it is not clear which type of lesion is recognized by photolyase. 4NQO was used to induce DNA damage by incubation of the DNA at 370C for 1 h with a molar ratio of 5 of the activated drug, 4-HAQO, in buffer containing 10% DMSO, 10 mM DTT, and 2 mM sodium citrate (pH 7.0). DNA was damaged by HN2 with molar ratios of 1 and 5 of drug to DNA phosphates at 37°C for 1 h in a solution of 20 mM Na2HPO4, 20 mM KH2PO4, and 70 mM NaCl (pH 7.0). Damage by both of these drugs was detected by a shift in electrophoretic mobility induced by the relaxation of supercoiled plasmid due to the induction of single-strand breaks (29) . Under these conditions the number of DNA cross-links induced per plasmid molecule by a molar ratio of 5 of HN2 to DNA phosphate is approximately 1,300 (22) , and the number of DNA adducts induced by 4NQO is approximately 218 (29) . Following incubation with each drug, the DNA was precipitated in ethanol and resuspended in water at a concentration of 250 ng/ml for use in the binding assays.
Binding assays. Binding activity to the UV-irradiated probe was measured by a gel mobility shift assay performed essentially as described previously (10) . All binding assay reaction mixtures were in a volume of 10 [lI and contained 0.2 ng of 32P-labeled UV-damaged probe and 4 ,ug of yeast extract, plus 50 ng of salmon sperm DNA and 300 ng of the alternating copolymer poly(dI-dC) (Pharmacia) to mask the effect of nonspecific DNA-binding proteins. The mixture was incubated at room temperature for 30 min in a buffer containing 12% glycerol, 12 mM HEPES (pH 7.9), 5 mM MgCl2, 4 mM Tris (pH 7.9), 0.6 mM EDTA, and 0.6 mM DTT. The binding of photolyase to DNA damaged by drugs was assessed by the addition of damaged plasmid DNA as an unlabeled competitor in the binding reaction mixtures. Each experiment included two controls for the competitor DNA: (i) undamaged plasmid DNA which had been exposed to all reaction conditions, except the drug, to demonstrate that competition was specific for damaged DNA, and (ii) the ethanol precipitate from a reaction mixture containing the highest concentration of the drug but no DNA to ensure that band disappearance was not due to inactivation of photolyase binding activity by residual unbound drug (see Fig. 2 , lanes labeled Mock). The products of the reactions were resolved on 5% nondenaturing polyacrylamide gels and run at 16 mM glycine, 2 mM EDTA), and the gels were dried onto Whatman 3MM paper and autoradiographed.
Survival assays. To determine drug cytotoxicity, logarithmically growing cells were treated with drugs in sterile water at a density of -107 cells per ml at 30'C for 2 h with agitation. Following treatment, cells were washed twice with sterile water, diluted in water, and plated in duplicate onto YPD or selective plates. After incubation at 30'C for 2 to 3 days, the colonies on each plate were counted.
RESULTS
Yeast photolyase binds to several drug-induced DNA lesions. Yeast nuclear extracts contain a binding activity that may be detected by a shift in electrophoretic mobility of a UV-irradiated DNA probe (28) . This activity corresponds to yeast photolyase: it requires the intact PHR1 gene and copurifies with photoreactivating activity. The double mutant strain XS was transformed both with the single-copy plasmid pc', with or without the RAD2 gene insert, and with either pc or p2j±, with or without the PHR1 insert. The two photolyase knockout strains were transformed with either the single-copy plasmid pc or the multicopy plasmid p2p. with or without the PHR1 insert. Protein extracts from the original and transformed yeast strains were tested for photolyase binding activity (Fig. 1) . Binding activity was present only in strains carrying a functional PHR1 allele; binding was absent in the double mutant (XS) and in both photolyase knockout strains (phrAA and phrAB). Transformation of the double mutant and both knockout strains with plasmid carrying the PHR1 gene restored binding activity in a dose-dependent manner. In the XS strain, the binding activity conferred by p2p.-PHR was 3.5-fold higher than that conferred by pc-PHR, as quantified by Phosphorlmager (Molecular Dynamics). Transformation with the plasmid vectors lacking the PHR1 gene had no effect on binding. In addition, transformation with plasmids carrying the frame- shifted PHR1 gene failed to produce binding activity in the double mutant. The presence of multiple bands, as seen for yeast cells transformed with p2pu-PHR, was observed previously (28) and may represent multiple independent binding events to probe DNA, which contains multiple pyrimidine dimers. These results demonstrate that the binding activity is dependent on the presence of the PHR1 gene. Binding was absent when the probe was undamaged (data not shown). Furthermore, binding to the DNA was decreased by the addition of UV-damaged competitor DNA, and unaffected by undamaged competitor (data not shown). Thus, the binding of photolyase was specific for UV damage, and independent of DNA sequence, as previously demonstrated (28) .
The affinity of photolyase for other forms of DNA damage was determined by competition experiments in which the binding reaction mixture contained competitor plasmid DNA treated with various DNA-damaging agents. The drugs selected for study were those for which the binding of XPE-BF was previously characterized (29) . These drugs were the anticancer drug cis-DDP and its isomer trans-DDP, which primarily form interstrand and intrastrand DNA cross-links (26); MNNG, which primarily methylates guanine and induces apurinic sites (39) ; the anticancer drug HN2, which forms interstrand and intrastrand cross-links as well as monoadducts (5); and 4NQO, which forms quinoline oxide adducts (39) .
DNA treated with cis-DDP, HN2, and MNNG competed with the UV-irradiated probe for binding (Fig. 2) . No competition was detected for DNA damaged with trans-DDP ( Fig.  2A) . No specific competition was detected with the 4NQO-damaged plasmid, since the same competition occurred when the DNA-damaging reaction was performed in the presence or absence of drug (Fig. 2D) . The competition observed in the absence of 4NQO adducts was probably due to damage The binding affinity of photolyase for DNA damaged by each of these damaging agents was determined by using the lesion frequencies given in Materials and Methods. Autoradiographs of binding assays were scanned by densitometry, and the amount of damaged competitor DNA required to reduce binding activity to 50% of that seen in the absence of competitor was calculated. Relative binding affinity was calculated as the total number of lesions needed to inhibit 50% of the binding relative to that required for UV-damaged competitor ( Table 1) .
The PHRI gene confers sensitivity to cis-DDP. Transformants of the XS double mutant strain were tested for cis-DDP sensitivity. Yeast strains carrying the rad2-1 mutation, either alone or in combination with the phrl-1 mutation, XS(pc-PHR)(pc') or XS(pc)(pc'), were hypersensitive to cis-DDP (Fig. 3) . The presence of wild-type PHRJ had no detectable effect on cisplatin sensitivity in the absence of a functional RAD2 allele. Thus, the nucleotide excision repair pathway, which includes RAD2 (13), repairs damage induced by cis-DDP. Since DNA photolyase is known to enhance the repair of damage induced by UV radiation, the effect of the PHR1 gene on the cisplatin sensitivity in a wild-type RAD2 background was investigated. Surprisingly, compared with XS(pc)(pc'-RAD2), cisplatin sensitivity was notably increased in XS(pc-PHR)(pc'-RAD2) and greatly increased in XS(p2,u-PHR)(pc'-RAD2) (Fig. 3) . Thus, the PHRI gene appears to confer sensitivity to cis-DDP in a dose-dependent manner.
This was tested further by using two photolyase knockout strains, phrAA and phrAB. Transformation of both knockout strains with pc-PHR and p2,u-PHR again increased sensitivity to cis-DDP in a dose-dependent manner (Fig. 4A and B) .
Transformation with each plasmid vector alone had no effect on sensitivity (not shown). In addition, the increased sensitivity Each point represent tions, from three or defined in Fig. 3 . or p2,u had no eff cis-DDP (Fig. 4C) 4NQO , while transformation with the multicopy construct significantly increased the sensitivity to both drugs. Transformation with the PHR1 gene had no effect on sensitivity to trans-DDP, which correlated with the lack of photolyase binding to trans-DDP-damaged DNA. DISCUSSION DNA photolyase repairs UV-induced cyclobutane pyrimidine dimers by the well-studied process of enzymatic photoreactivation as well as by a less understood stimulation of NER (31, 33, 34 have no detectable binding to DNA damaged by trans-DDP Ls the arithmetic mean of six to eight determinaand 4NQO (10, 28, 29) . However, unlike photolyase, XPE-BF four independent experiments. Symbols are as has no detectable photoreactivating activity (28) , and increased expression of XPE-BF correlates with resistance rather than sensitivity to cis-DDP (11). The cDNAs for monkey UV-DDB protein (42) and human fect on the sensitivity of XS(pc-RAD2) to XPE-BF (18a), which have been cloned by amino acid analysis Therefore, the expression of intact photoof purified monkey and human proteins, are 99% homologous ast cells conferred sensitivity to cis-DDP.
to each other but contain no significant homology to yeast confers sensitivity to other DNA-damaging photolyase. Thus, although photolyase and XPE-BF have nine whether the decreased sensitivity of distinct primary structures, it is possible that their secondary 's was restricted to cis-DDP, transformants and/or tertiary structures share a similar conformation for the mutant were exposed to the DNA-damaging recognition of damaged DNA, perhaps by binding to DNA MNNG, HN2, and 4NQO. Yeast strains that is bent or unwound in the vicinity of the lesion (29) . It rad2-1 allele, with or without intact PHR1, Brown et al. recently reported that the expression of the e to all four drugs, indicating that the NER yeast gene IXRM is also associated with an increase in cis-DDP {A damaged by these drugs (Fig. 5) . The sensitivity (6) . Like photolyase, Ixrl protein also binds to
Terence in MNNG sensitivity between yeast cis-DDP-damaged DNA, but unlike photolyase, it does not rad2-1 mutant allele and the RAD2 transbind to cyclobutane dimers. Ixrl is a member of a family of ) may reflect the existence of alternative proteins defined by the HMG box, an amino acid motif first S. cerevisiae. For example, alkylbase glycodescribed for the high-mobility group (HMG) proteins (23 sensitivity to certain DNA-damaging agents. One possibility is that the binding of photolyase shields some DNA lesions from repair while enhancing the repair of other lesions. Some DNA lesions may have structural interactions with photolyase that block access by the NER machinery. As a result, yeast photolyase enhances the repair of cyclobutane dimers but interferes with the repair of damage induced by cis-DDP, MNNG, HN2, and 4NQO (Fig. 6) . This model is supported by the fact that transformation of the double mutant strain with PHR1 alone had little effect on sensitivity to these drugs, indicating that the sensitizing effect of photolyase is lost in the absence of a functional NER pathway. This model for repair interference has also been proposed as the explanation for IXRJ-mediated sensitivity to cis-DDP (6) .
A second possibility is that the binding of photolyase to lesions that it cannot repair may act as a signal for cell death. In mammalian cells, the induction of DNA damage by several agents, including cis-DDP and alkylating agents, leads to programmed cell death, or apoptosis (2, 40) . In S. cerevisiae, the induction of one double-strand break in a nonessential plasmid will lead to death of the cell (3). There may even be indirect evidence that drug-induced bulky adducts will also lead to death in S. cerevisiae through a pathway that involves photolyase. Sebastian et al. (38) have reported that transcription of the photolyase gene is induced 10-to 20-fold by several DNA-damaging agents, including UV radiation, 4NQO, MNNG, and methyl methanesulfonate. The induction of PHR1 by UV radiation makes physiological sense, since it should enhance survival. However, induction of PHRJ expression in response to MNNG or 4NQO seems counterproductive, since PHR1 interferes with survival after exposure to these drugs. This response becomes explicable if the yeast cell has a PHR1-dependent pathway for cell death in response to DNA damage induced by cis-DDP, MNNG, or 4NQO.
It should be noted that these two possibilities are not necessarily mutually exclusive, and that other explanations are also possible. For example, binding of photolyase to some DNA adducts may block replication or transcription. Alternatively, binding may interfere with control mechanisms that protect the cell by arresting the cell cycle in response to DNA damage.
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In conclusion, photolyase appears to have paradoxical functions in S. cerevisiae. Depending on the DNA lesion, photolyase can either enhance or interfere with survival. The protein enhances survival after UV radiation by either photoreactivation or stimulation of NER. Conversely, it interferes with survival after exposure to cis-DDP, MNNG, HN2, and 4NQO through a mechanism that appears to depend on its binding activity. This interference with survival was particularly notable with a multicopy plasmid yielding a 3.5-fold overexpression of photolyase, so that the physiological relevance for wild-type yeast strains remains a question for further investigation. Nevertheless, such levels of photolyase are well within the 10-to 20-fold range of induction of photolyase by DNA-damaging agents (38) . Furthermore, the studies presented here suggest new ways for understanding drug resistance. Mammalian cells may also contain similar proteins that enhance or interfere with survival after exposure to different drugs. Thus, cells that gain resistance to one drug by expressing higher levels of one protein might become more sensitive to another drug. The study of such proteins may have implications for cancer chemotherapy. 
